Free Trial
→ The Robotics Revolution has arrived … and one $7 stock could take off as a result. (From Weiss Ratings) (Ad) Buy GILD Stock  Free GILD Stock Alerts

Gilead Sciences (GILD) Short Interest Ratio & Short Volume

Gilead Sciences logo
$110.09 -2.91 (-2.58%)
Closing price 06/10/2025 04:00 PM Eastern
Extended Trading
$111.00 +0.91 (+0.83%)
As of 06/10/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Gilead Sciences Short Interest Data

Gilead Sciences (GILD) has a short interest of 24.68 million shares, representing 1.99% of the float (the number of shares available for trading by the public). This marks a 4.71% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.5, indicating that it would take 2.5 days of the average trading volume of 7.73 million shares to cover all short positions.

Current Short Interest
24,680,000 shares
Previous Short Interest
23,570,000 shares
Change Vs. Previous Month
+4.71%
Dollar Volume Sold Short
$2.48 billion
Short Interest Ratio
2.5 Days to Cover
Last Record Date
May 15, 2025
Outstanding Shares
1,243,929,000 shares
Float Size
1,240,000,000 shares
Short Percent of Float
1.99%
Today's Trading Volume
8,870,755 shares
Average Trading Volume
7,734,130 shares
Today's Volume Vs. Average
115%
Short Selling Gilead Sciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Gilead Sciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

GILD Short Interest Over Time

GILD Days to Cover Over Time

GILD Percentage of Float Shorted Over Time

Gilead Sciences Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/202524,680,000 shares $2.48 billion +4.7%2.0%2.5 $100.34
4/30/202523,570,000 shares $2.51 billion +17.4%1.9%2.4 $106.54
4/15/202520,080,000 shares $2.12 billion -6.1%1.6%2.1 $105.68
3/31/202521,390,000 shares $2.40 billion -4.3%1.7%2.3 $112.05
3/15/202522,340,000 shares $2.49 billion -1.1%1.8%2.7 $111.44
2/28/202522,580,000 shares $2.58 billion +6.7%1.8%2.9 $114.31
2/15/202521,160,000 shares $2.20 billion -7.7%1.7%3 $104.08
1/31/202522,930,000 shares $2.23 billion -8.9%1.9%3.2 $97.20
1/15/202525,170,000 shares $2.33 billion -1.9%2.0%3.6 $92.38
12/31/202425,660,000 shares $2.37 billion +16.7%2.1%4 $92.37
12/15/202421,980,000 shares $2.02 billion -6.1%1.8%3.3 $91.86
11/30/202423,410,000 shares $2.17 billion +29.6%1.9%3.4 $92.58
11/15/202418,060,000 shares $1.60 billion +1.8%1.5%2.7 $88.40
10/31/202417,740,000 shares $1.58 billion +7.7%1.4%2.8 $88.82
10/15/202416,480,000 shares $1.41 billion -7.1%1.3%2.7 $85.82
9/30/202417,740,000 shares $1.49 billion -11.1%1.4%2.7 $83.84
9/15/202419,950,000 shares $1.65 billion +0.8%1.6%3 $82.81
8/31/202419,800,000 shares $1.56 billion +18.1%1.6%2.8 $79.00
8/15/202416,770,000 shares $1.25 billion -6.0%1.4%2.3 $74.34
7/31/202417,840,000 shares $1.36 billion -16.1%1.4%2.4 $76.06
7/15/202421,250,000 shares $1.50 billion -7.6%1.7%2.8 $70.81
6/30/202423,000,000 shares $1.58 billion +22.3%1.9%3.1 $68.61
6/15/202418,810,000 shares $1.22 billion -26.0%1.5%2.5 $65.06
5/31/202425,430,000 shares $1.63 billion +17.2%2.1%3.6 $64.27
5/15/202421,700,000 shares $1.45 billion +2.6%1.8%3.2 $67.01
4/30/202421,160,000 shares $1.38 billion -0.1%N/A2.9 $65.20
4/15/202421,180,000 shares $1.43 billion -6.2%N/A2.9 $67.75
3/31/202422,570,000 shares $1.65 billion +17.3%N/A3 $73.25
3/15/202419,250,000 shares $1.42 billion -2.1%1.6%2.7 $73.69
2/29/202419,670,000 shares $1.42 billion -1.1%1.6%2.7 $72.10
2/15/202419,880,000 shares $1.46 billion +27.0%1.6%2.8 $73.37
1/31/202415,660,000 shares $1.23 billion -8.6%1.3%2.2 $78.26
1/15/202417,140,000 shares $1.48 billion +0.6%1.4%2.6 $86.38
12/31/202317,040,000 shares $1.38 billion -7.9%N/A2.7 $81.01
12/15/202318,500,000 shares $1.49 billion +6.2%N/A3 $80.33
11/30/202317,420,000 shares $1.33 billion -3.9%N/A3 $76.60
11/15/202318,130,000 shares $1.36 billion -7.0%N/A3.3 $75.04
10/31/202319,500,000 shares $1.53 billion -4.2%1.6%3.6 $78.54
10/15/202320,350,000 shares $1.58 billion +0.5%1.6%3.9 $77.65
9/30/202320,240,000 shares $1.52 billion +10.4%1.6%3.8 $74.94
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)

Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.

For the moment, you can watch this interview free of charge – just click here.
9/15/202318,330,000 shares $1.39 billion +0.4%1.5%3.3 $75.67
8/31/202318,250,000 shares $1.40 billion -7.0%1.5%3.2 $76.48
8/15/202319,630,000 shares $1.56 billion +4.2%1.6%3.4 $79.64
7/31/202318,840,000 shares $1.43 billion +7.2%N/A3.3 $76.14
7/15/202317,570,000 shares $1.36 billion +1.3%N/A3 $77.19
6/30/202317,340,000 shares $1.34 billion +6.3%N/A3.2 $77.07
6/15/202316,320,000 shares $1.29 billion +6.8%N/A3 $79.00
5/31/202315,280,000 shares $1.18 billion -15.0%N/A2.7 $76.94
5/15/202317,980,000 shares $1.41 billion -6.7%N/A3.4 $78.38
4/30/202319,280,000 shares $1.59 billion +26.4%N/A3.4 $82.21
4/15/202315,250,000 shares $1.27 billion -1.5%N/A2.6 $83.00
3/31/202315,480,000 shares $1.28 billion +1.8%N/A2.6 $82.97
3/15/202315,200,000 shares $1.21 billion -2.9%N/A2.5 $79.65
2/28/202315,660,000 shares $1.26 billion -0.6%N/A2.3 $80.53
2/15/202315,760,000 shares $1.34 billion +3.9%N/A2.3 $85.05
1/31/202315,170,000 shares $1.27 billion +1.6%N/A2.1 $83.94
1/15/202314,930,000 shares $1.29 billion -8.0%N/A1.9 $86.27
12/30/202216,220,000 shares $1.39 billion +9.9%N/A2.1 $85.85
12/15/202214,760,000 shares $1.28 billion -16.0%N/A1.8 $86.58
11/30/202217,560,000 shares $1.54 billion -15.3%N/A2.1 $87.83
11/15/202220,730,000 shares $1.72 billion +8.7%N/A2.5 $83.00
10/31/202219,070,000 shares $1.50 billion +15.8%N/A2.4 $78.46
10/15/202216,470,000 shares $1.09 billion +0.1%N/A2.3 $66.17
9/30/202216,450,000 shares $1.01 billion -1.4%N/A2.4 $61.69
9/15/202216,690,000 shares $1.08 billion -0.5%N/A2.5 $65.00
8/31/202216,770,000 shares $1.06 billion -1.6%N/A2.5 $63.47
8/15/202217,040,000 shares $1.13 billion +20.3%N/A2.5 $66.21
7/31/202214,160,000 shares $846.06 million -14.5%N/A2 $59.75
7/15/202216,560,000 shares $1.04 billion +13.0%N/A2.2 $62.60
6/30/202214,650,000 shares $905.52 million -6.4%N/A1.9 $61.81
6/15/202215,650,000 shares $913.80 million +6.6%N/A1.9 $58.39
5/31/202214,680,000 shares $952.00 million -12.9%N/A1.7 $64.85
5/15/202216,850,000 shares $1.05 billion +0.9%N/A1.7 $62.37
4/30/202216,700,000 shares $990.98 million +8.7%N/A1.6 $59.34
4/15/202215,370,000 shares $950.17 million +6.3%N/A1.4 $61.82
3/31/202214,460,000 shares $859.65 million -2.6%N/A1.3 $59.45
3/15/202214,840,000 shares $865.47 million -20.3%N/A1.4 $58.32
2/28/202218,630,000 shares $1.13 billion -16.2%N/A1.9 $60.40
2/15/202222,240,000 shares $1.36 billion -7.9%N/A2.3 $61.33
1/31/202224,150,000 shares $1.66 billion +10.4%N/A2.9 $68.68
1/15/202221,880,000 shares $1.57 billion +2.7%N/A0 $71.77
12/31/202121,300,000 shares $1.55 billion -4.1%N/A3 $72.61
12/15/202122,200,000 shares $1.58 billion +1.4%N/A3.2 $71.21
11/30/202121,890,000 shares $1.51 billion -5.3%N/A3.2 $68.93
11/15/202123,120,000 shares $1.55 billion +5.5%N/A3.5 $67.20
10/29/202121,920,000 shares $1.42 billion -8.7%N/A3.4 $64.88
10/15/202124,010,000 shares $1.62 billion -1.1%N/A3.8 $67.63
9/30/202124,280,000 shares $1.70 billion +16.2%N/A3.9 $69.85
9/15/202120,900,000 shares $1.50 billion -6.9%N/A3.4 $71.76
8/31/202122,450,000 shares $1.63 billion -12.7%N/A3.7 $72.78
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)

Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.

For the moment, you can watch this interview free of charge – just click here.
8/13/202125,700,000 shares $1.83 billion -0.1%N/A4.1 $71.16
7/30/202125,730,000 shares $1.76 billion -5.5%N/A4 $68.29
7/15/202127,220,000 shares $1.86 billion +12.3%N/A4.1 $68.30
6/30/202124,230,000 shares $1.67 billion +0.9%N/A3.5 $68.86
6/15/202124,020,000 shares $1.64 billion +1.4%N/A3.4 $68.09
5/28/202123,690,000 shares $1.57 billion -7.9%N/A3.2 $66.11
5/14/202125,720,000 shares $1.77 billion -10.2%2.1%3.3 $68.91
4/30/202128,640,000 shares $1.83 billion +10.1%2.3%3.7 $63.84
4/15/202126,010,000 shares $1.70 billion +11.0%2.1%3.4 $65.30
3/31/202123,440,000 shares $1.54 billion +4.1%1.9%2.8 $65.50
3/15/202122,520,000 shares $1.39 billion -5.5%1.8%2.4 $61.56
2/26/202123,830,000 shares $1.50 billion +3.1%1.9%2.6 $62.79
2/12/202123,110,000 shares $1.55 billion +7.1%1.9%2.6 $66.92
1/29/202121,580,000 shares $1.40 billion -3.5%1.7%2.3 $64.68
1/15/202122,370,000 shares $1.40 billion +3.7%1.8%2.3 $62.40
12/31/202021,570,000 shares $1.22 billion +22.1%1.7%2.2 $56.65
12/15/202017,670,000 shares $1.06 billion -14.8%1.4%1.9 $59.84
11/30/202020,730,000 shares $1.24 billion -4.5%1.7%2.2 $60.03
11/15/202021,710,000 shares $1.32 billion -4.4%1.7%2.3 $60.59
10/30/202022,700,000 shares $1.33 billion +10.7%1.8%2.4 $58.53
10/15/202020,500,000 shares $1.31 billion +5.9%1.6%2.1 $64.05
9/30/202019,360,000 shares $1.22 billion +7.9%1.6%2.2 $63.19
9/15/202017,950,000 shares $1.19 billion +11.0%1.4%2.1 $66.20
8/31/202016,170,000 shares $1.08 billion -14.1%1.3%1.9 $66.75
8/14/202018,830,000 shares $1.29 billion -11.7%1.5%2 $68.50
7/31/202021,330,000 shares $1.48 billion -3.4%1.7%2.2 $69.53
7/15/202022,090,000 shares $1.69 billion -3.7%1.8%1.7 $76.65
6/30/202022,930,000 shares $1.76 billion -9.1%1.8%1.4 $76.94
6/15/202025,220,000 shares $1.87 billion +4.5%2.0%1.4 $73.97

GILD Short Interest - Frequently Asked Questions

What is Gilead Sciences' current short interest?

Short interest is the volume of Gilead Sciences shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 24,680,000 shares of GILD short. 1.99% of Gilead Sciences' shares are currently sold short. Learn More on Gilead Sciences' current short interest.

What is a good short interest ratio for Gilead Sciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GILD shares currently have a short interest ratio of 2.0. Learn More on Gilead Sciences's short interest ratio.

Which institutional investors are shorting Gilead Sciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Gilead Sciences: Quaker Wealth Management LLC, Jane Street Group LLC, Parallax Volatility Advisers L.P., Millennium Management LLC, Cubist Systematic Strategies LLC, Caption Management LLC, Nomura Holdings Inc., BNP Paribas Financial Markets, Eisler Capital Management Ltd., PEAK6 LLC, Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, Capital Fund Management S.A., Hsbc Holdings PLC, Arrowpoint Investment Partners Singapore Pte. Ltd., Simplex Trading LLC, JPMorgan Chase & Co., Citigroup Inc., Delta Accumulation LLC, Sheaff Brock Investment Advisors LLC, LPL Financial LLC, Readystate Asset Management LP, Allianz Asset Management GmbH, Bank of New York Mellon Corp, SG Americas Securities LLC, and IMC Chicago LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Gilead Sciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.99% of Gilead Sciences' floating shares are currently sold short.

Is Gilead Sciences' short interest increasing or decreasing?

Gilead Sciences saw a increase in short interest in May. As of May 15th, there was short interest totaling 24,680,000 shares, an increase of 4.7% from the previous total of 23,570,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Gilead Sciences' float size?

Gilead Sciences currently has issued a total of 1,243,929,000 shares. Some of Gilead Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Gilead Sciences currently has a public float of 1,240,000,000 shares.

How does Gilead Sciences' short interest compare to its competitors?

1.99% of Gilead Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Gilead Sciences: Amgen Inc. (2.68%), Vertex Pharmaceuticals Incorporated (1.88%), Regeneron Pharmaceuticals, Inc. (2.69%), Alnylam Pharmaceuticals, Inc. (2.89%), Biogen Inc. (2.28%), United Therapeutics Co. (4.77%), Incyte Co. (4.96%), Neurocrine Biosciences, Inc. (4.22%), Exelixis, Inc. (7.09%), BioMarin Pharmaceutical Inc. (2.38%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

What does it mean to sell short Gilead Sciences stock?

Short selling GILD is an investing strategy that aims to generate trading profit from Gilead Sciences as its price is falling. GILD shares are trading down $1.85 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Gilead Sciences?

A short squeeze for Gilead Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GILD, which in turn drives the price of the stock up even further.

How often is Gilead Sciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GILD, twice per month. The most recent reporting period available is May, 15 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:GILD) was last updated on 6/11/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...
Porter & Company | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...
Weiss Ratings | Sponsored
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
An AI run of epic proportions is only getting started
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored